Clinical Trials Logo

Clinical Trial Summary

Obese people suffer from significant functional limitations, which affect their quality of life and limit their physical activity level. Functional abilities are largely determined by neuromuscular properties, i.e the ability to produce a torque or a power, and fatigability, i.e the ability to maintain a high level of torque production during repeated contractions. Our previous studies on "healthy" obese adolescents (i.e without inflammation or metabolic disorder) suggests that obesity has positive effects on the neural and muscular factors responsible for torque production, with chronic overload acting as a strength training . However, this high torque level is associated with higher fatigability. These results are in contrast with the data obtained on adult obese patients (young and elderly), in whom torque production and fatigability appear to be more impaired, probably due to the development of metabolic disorders associated with obesity (inflammation, insulin resistance and lipid infiltration in muscle) and aging. The respective effects of mechanical overload, metabolic disorders (insulin resistance and lipid infiltration) and aging on neural and muscular factors of torque production and neuromuscular fatigue etiology are not currently known in young adult obese of elderly. Their relationship to the clinical symptoms of mobility troubles is also unknown. However, this knowledge is crucial for designing physical activity programs tailored and adapted to the level of metabolic impairment and age of obese patients. The hypothesis is that mechanical overload associated with obesity has positive effects on torque production in the absence of metabolic alteration and the effect of aging but negative effects on fatigability, mainly due to muscular factors; the insulin resistance increases peripheral fatigue (due to an alteration in the excitability of the sarcolemma during fatiguing exercise), central fatigue, and slows recovery; the development of inflammation and lipid infiltration, which are more pronounced in obese subjects, further affect torque production through inhibition of the nervous control and alteration of contractile properties and muscle architecture, all these phenomena leading to a decrease in torque production and increased fatigability, cumulating with the effects of the ageing (sarcopenia).


Clinical Trial Description

The limited data available in the literature suggest that insulin resistance, low-grade inflammation and muscle lipid infiltration may negatively impact torque production capacity and promote neuromuscular fatigability. Insulin resistance thus has effects on blood perfusion of active muscles, via effects on the autonomic nervous system (Petrofsky and al. 2009). Insulin resistance is also associated with a disruption of Na+/K+ pump activity, excitation-contraction coupling, intracellular ATP concentration (Orlando and al. 2016) and mitochondrial function (Slattery and al. 2014). All these effects are expected to increase the development of peripheral fatigue in obese patients with type 2 diabetes and impaired mitochondrial function is expected to result in impaired post-exercise recovery capacity. Inflammation can also affect the torque production. Some studies have shown a negative correlation between muscle torque production and inflammatory status in obese adolescents (Ruiz and al. 2008) and seniors (Visser and al. 2002). Inflammation is associated with reduced muscle mass, which may result from inhibition of protein synthesis (Guillet and al. 2012). Inflammation could also have negative effects on the nervous factors of torque production, via the stimulation of afferences III and IV, as suggested in the healthy subject (Dousset and al. 2007). However, this has never been demonstrated. Finally, oedema associated with the inflammatory reaction could modify the architecture and muscle dimensions, as demonstrated in healthy subjects (Ishikawa and al. 2006) or those suffering from inflammatory diseases (Kaya and al. 2013). To date, the consequences of low-grade inflammation, combined or not with aging, on the muscle and nervous factors of force production in obese adults have yet to be characterized experimentally. Muscle lipid infiltration can also have negative effects on muscle protein synthesis (Tardif and al. 2014) and especially on strength. This has been frequently reported in non-obese elderly people (Sipilä and Suominen 1994). Interestingly, another study reported a negative correlation between intramuscular lipid content and level of quadriceps voluntary activation in non-obese elderly people (Yoshida and al. 2012), which may explain the correlation discussed above. To our knowledge, no data are available for adult obese patients. However, it can be assumed that lipid infiltration would have inhibitory effects on the level of activation of motor units, and therefore on the production of force. It is also likely that lipid infiltration limits muscle architectural adaptations to overweight (contractile and adipose tissues competing to develop in a restricted muscle volume). Mathematical modelling of the effects of lipid infiltration on muscle mechanics (Rahemi and al. 2015) suggests that intramuscular lipids could disrupt contractile activity by limiting the shortening of muscle fascicles, and transverse muscle deformation during muscle contraction. However, these theoretical predictions have yet to be confirmed by experimental data. The PLANEUROB research project is a physiological observational study comparing the respective effects of mechanical overload, metabolic disorders and age on torque production, fatigability and functional capacity in obese people. Subjects will have to perform a fatigue protocol, an adapted Margaria test and a 6 minutes walking test in one session. Blood samples, muscular ultrasound scanner and physical activity assessment will also be achieved. Data will be analysed using LabChart 7.3 Pro software (ADInstrument, New South Wales, Australia), ImageJ (NIH Image, Bethesda, Maryland, USA) and Statistica 8.0 software (StatSoft, Inc.) and significance will be accepted at a two-sided alpha level of p<.05. The normality and homogeneity of the variables will be checked respectively from a Shapiro- Wilk test and a Barlett test. If normality and homogeneity of the variables are verified, absolute values of variables (Torque, EMG, mean grey, etc.) will be compared using two factors (age x metabolic disorders) analyses of variance (ANOVA) with repeated measures. If analyses reveal a significant effect of any factor or interaction of factors, post-hoc Newman-Keuls tests will be performed to determine differences between the different conditions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04106570
Study type Interventional
Source University Hospital, Clermont-Ferrand
Contact
Status Terminated
Phase N/A
Start date December 2, 2019
Completion date June 26, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2